You just read:

Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies

News provided by

CSL Behring

Mar 21, 2011, 05:00 ET